Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.3.23 (
GAS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Reactive oxygen species are known to be involved in several cellular processes, including cell signaling.
SOD2
is a key enzyme in the conversion of reactive oxygen species and has been implicated in a host of disease states, including cancer. Using an integrated, whole-cell approach encompassing epigenetics, genomics, and proteomics, we have defined the role of
SOD2
in multiple myeloma. We show that the
SOD2
promoter is methylated in several cell lines and there is a correlative decrease in expression. Furthermore, myeloma patient samples have decreased
SOD2
expression compared with healthy donors. Overexpression of
SOD2
results in decreased proliferation and altered sensitivity to 2-methoxyestradiol-induced DNA damage and apoptosis. Genomic profiling revealed regulation of 65 genes, including genes involved in tumorigenesis, and proteomic analysis identified activation of the JAK/STAT pathway. Analysis of nearly 400 activated transcription factors identified 31 transcription factors with altered DNA binding activity, including XBP1, NFAT, forkhead, and
GAS
binding sites. Integration of data from our gestalt molecular analysis has defined a role for
SOD2
in cellular proliferation, JAK/STAT signaling, and regulation of several transcription factors.
...
PMID:Integrated molecular profiling of SOD2 expression in multiple myeloma. 1719 97